Clinical Trial: A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07450976) titled 'A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer' on Feb. 27.

Brief Summary: This is a multicenter, Phase 2 clinical trial to evaluate the efficacy and safety, PK and immunogenicity of SHR-A1904 in patients with advanced or metastatic biliary tract cancer (BTC). Patients will treat with SHR-A1904 until unacceptable toxicity or disease progression.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Biliary Tract Cancer

Intervention: DRUG: SHR-A1904 for Injection

SHR-A1904 for injection, different doses.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Suncadia Biopharmace...